Brief: Crescita Therapeutics total revenue $1.1 mln versus $29,000 last year
14/11/2016 22:45
Nov 14 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* Qtrly total revenue $1.1 million versus $29,000 last year
* Crescita Therapeutics Inc - qtrly net loss from continuing
operations (excluding immunology group which was discontinued)
was $1.4 million versus $2.3 million
* Crescita Therapeutics(tm) announces 2016 third quarter
results
Source text for Eikon: ID:nCNWNJg1ma
Further company coverage: CTX.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium